Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Tango Therapeutics (TNGX)
NASDAQ:TNGX
Tango Therapeutics (TNGX) Stock Price & Analysis
57 Followers
TNGX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.47 - $13.03
Previous Close$9.03
Volume3.32M
Average Volume (3M)674.69K
Market Cap
$927.09M
Enterprise Value$606.71M
Total Cash (Recent Filing)$359.88M
Total Debt (Recent Filing)$39.51M
Price to Earnings (P/E)-8.1
Beta0.99
Next Earnings
Mar 25, 2024EPS Estimate
-$0.27Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.11
Shares Outstanding101,989,696
10 Day Avg. Volume889,808
30 Day Avg. Volume674,691
Standard Deviation0.31
R-Squared0.03
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)3.35
Price to Sales (P/S)37.05
Price to Cash Flow (P/CF)-6.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue18.66
Enterprise Value/Gross Profit24.41
Enterprise Value/Ebitda-6.16
Forecast
1Y Price Target
$17.00Price Target Upside88.26% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Tango Therapeutics News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
TNGX FAQ
What was Tango Therapeutics’s price range in the past 12 months?
Tango Therapeutics lowest stock price was $2.47 and its highest was $13.03 in the past 12 months.
What is Tango Therapeutics’s market cap?
Currently, no data Available
When is Tango Therapeutics’s upcoming earnings report date?
Tango Therapeutics’s upcoming earnings report date is Mar 25, 2024 which is 32 days ago.
How were Tango Therapeutics’s earnings last quarter?
Tango Therapeutics released its earnings results on Nov 08, 2023. The company reported -$0.23 earnings per share for the quarter, beating the consensus estimate of -$0.337 by $0.107.
Is Tango Therapeutics overvalued?
According to Wall Street analysts Tango Therapeutics’s price is currently Undervalued.
Does Tango Therapeutics pay dividends?
Tango Therapeutics does not currently pay dividends.
What is Tango Therapeutics’s EPS estimate?
Tango Therapeutics’s EPS estimate is -$0.27.
How many shares outstanding does Tango Therapeutics have?
Tango Therapeutics has 101,989,690 shares outstanding.
What happened to Tango Therapeutics’s price movement after its last earnings report?
Tango Therapeutics reported an EPS of -$0.23 in its last earnings report, beating expectations of -$0.337. Following the earnings report the stock price went up 3.833%.
Which hedge fund is a major shareholder of Tango Therapeutics?
Among the largest hedge funds holding Tango Therapeutics’s share is Deerfield Management Company, LP. It holds Tango Therapeutics’s shares valued at 15M.
---
Tango Therapeutics Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$17.00 (88.26% Upside)
$17.00 (88.26% Upside)
Blogger Sentiment
Neutral
TNGX Sentiment 50%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 710.1K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $2.3M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 3.6%
Last 30 Days ▲ 0.2%
Last 30 Days ▲ 0.2%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
110.98%
12-Months-Change
Fundamentals
Return on Equity
-36.40%
Trailing 12-Months
Asset Growth
-7.75%
Trailing 12-Months
Company Description
Tango Therapeutics
BCTG Acquisition Corp is a blank check company.
---
TNGX Stock 12 Months Forecast
Average Price Target
$17.00
▲(88.26% Upside)
Technical Analysis
Arvinas Holding Company
―
Nektar Therapeutics
―
Crispr Therapeutics AG
―
Alnylam Pharma
―
Best Analysts Covering TNGX
1 Year
1 Year Success Rate
5/7 ratings generated profit
1 Year Average Return
+29.73%
reiterated a buy rating 4 months ago
Copying Robert Burns's trades and holding each position for 1 Year would result in 71.43% of your transactions generating a profit, with an average return of +29.73% per trade.
---